Skip to main content

Thrivent Financial for Lutherans

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 314984 Minneapolis, MN

Position in REGN

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$6,521,080
+$539,860 QoQ
Shares Held
8,440
+8.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 79.70379146919431.ToString("F0")% Shared 0.ToString("F0")% None 20.296208530805686.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. REGN ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 REGN
Regeneron Pharmaceuticals, Inc.
This page
8,440 $6,521,080

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,521,080 8,440
2025-12-31 $5,981,220 7,749
2025-09-30 $4,236,704 7,535
2025-06-30 $4,994,325 9,513
2025-03-31 $87,707,666 138,290
2024-12-31 $89,179,441 125,194
2024-09-30 $9,587,308 9,120
2024-06-30 $8,212,748 7,814
2024-03-31 $7,551,696 7,846
2023-12-31 $8,782,021 9,999
2023-09-30 $11,167,567 13,570
2023-06-30 $64,348,848 89,555
2023-03-31 $93,117,395 113,327
2022-12-31 $119,852,475 166,118
2022-09-30 $109,065,342 158,325
2022-06-30 $72,953,125 123,413
2022-03-31 $14,390,245 20,604
2021-12-31 $33,460,455 52,984
2021-09-30 $33,284,294 54,999
2021-06-30 $30,830,849 55,199
2021-03-31 $18,288,280 38,653
2020-12-31 $28,055,163 58,072
2020-09-30 $24,663,347 44,059
2020-06-30 $28,122,873 45,094
2020-03-31 $1,777,863 3,641